These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22046345)

  • 21. Prevalence of transmitted drug resistance among ART-naïve HIV-infected individuals, Beijing, 2015-2018.
    Li R; Song C; Chen D; Li C; Hao Y; Zeng H; Han J; Zhao H
    J Glob Antimicrob Resist; 2022 Mar; 28():241-248. PubMed ID: 35092830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increase in HIV-1-transmitted drug resistance among ART-naïve youths at the China-Myanmar border during 2009 ~ 2017.
    Ding Y; Chen M; Wang J; Yang Y; Feng Y; Wang L; Duan S; Lin Q; Xing H; Ma Y; Han M; Ma L
    BMC Infect Dis; 2021 Jan; 21(1):93. PubMed ID: 33478415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort.
    Machnowska P; Meixenberger K; Schmidt D; Jessen H; Hillenbrand H; Gunsenheimer-Bartmeyer B; Hamouda O; Kücherer C; Bannert N;
    PLoS One; 2019; 14(1):e0209605. PubMed ID: 30650082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic.
    Pineda-Peña AC; Schrooten Y; Vinken L; Ferreira F; Li G; Trovão NS; Khouri R; Derdelinckx I; De Munter P; Kücherer C; Kostrikis LG; Nielsen C; Littsola K; Wensing A; Stanojevic M; Paredes R; Balotta C; Albert J; Boucher C; Gomez-Lopez A; Van Wijngaerden E; Van Ranst M; Vercauteren J; Vandamme AM; Van Laethem K
    PLoS One; 2014; 9(7):e101738. PubMed ID: 25003369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transmission of HIV drug resistance and non-B subtype distribution in the Spanish cohort of antiretroviral treatment naïve HIV-infected individuals (CoRIS).
    García F; Pérez-Cachafeiro S; Guillot V; Alvarez M; Pérez-Romero P; Pérez-Elías MJ; Viciana I; Blanco JR; López-Dieguez M; de Mendoza C;
    Antiviral Res; 2011 Aug; 91(2):150-3. PubMed ID: 21663768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low prevalence of transmitted HIV type 1 drug resistance among antiretroviral-naive adults in a rural HIV clinic in Kenya.
    Hassan AS; Mwaringa SM; Obonyo CA; Nabwera HM; Sanders EJ; Rinke de Wit TF; Cane PA; Berkley JA
    AIDS Res Hum Retroviruses; 2013 Jan; 29(1):129-35. PubMed ID: 22900472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Provincial and national prevalence estimates of transmitted HIV-1 drug resistance in South Africa measured using two WHO-recommended methods.
    Hunt GM; Ledwaba J; Kalimashe M; Salimo A; Cibane S; Singh B; Puren A; Dean NE; Morris L; Jordan MR
    Antivir Ther; 2019; 24(3):203-210. PubMed ID: 30741163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transmitted HIV Drug Resistance Is High and Longstanding in Metropolitan Washington, DC.
    Kassaye SG; Grossman Z; Balamane M; Johnston-White B; Liu C; Kumar P; Young M; Sneller MC; Sereti I; Dewar R; Rehm C; Meyer W; Shafer R; Katzenstein D; Maldarelli F
    Clin Infect Dis; 2016 Sep; 63(6):836-843. PubMed ID: 27307507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.
    Hamers RL; Wallis CL; Kityo C; Siwale M; Mandaliya K; Conradie F; Botes ME; Wellington M; Osibogun A; Sigaloff KC; Nankya I; Schuurman R; Wit FW; Stevens WS; van Vugt M; de Wit TF;
    Lancet Infect Dis; 2011 Oct; 11(10):750-9. PubMed ID: 21802367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016.
    Rossetti B; Di Giambenedetto S; Torti C; Postorino MC; Punzi G; Saladini F; Gennari W; Borghi V; Monno L; Pignataro AR; Polilli E; Colafigli M; Poggi A; Tini S; Zazzi M; De Luca A;
    HIV Med; 2018 Oct; 19(9):619-628. PubMed ID: 29932313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [HIV infection in immigrants in Spain: Epidemiological characteristics and clinical presentation in the CoRIS Cohort (2004-2006)].
    Caro-Murillo AM; Gutiérrez F; Manuel Ramos J; Sobrino P; Miró JM; López-Cortés LF; Tural C; Moreno A; de Los Santos I; Murillas J; Camino X; Salavert M; Rubio R; Moreno S; del Amo J;
    Enferm Infecc Microbiol Clin; 2009; 27(7):380-8. PubMed ID: 19427080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.
    Hofstra LM; Sauvageot N; Albert J; Alexiev I; Garcia F; Struck D; Van de Vijver DAMC; Åsjö B; Beshkov D; Coughlan S; Descamps D; Griskevicius A; Hamouda O; Horban A; Van Kasteren M; Kolupajeva T; Kostrikis LG; Liitsola K; Linka M; Mor O; Nielsen C; Otelea D; Paraskevis D; Paredes R; Poljak M; Puchhammer-Stöckl E; Sönnerborg A; Staneková D; Stanojevic M; Van Laethem K; Zazzi M; Zidovec Lepej S; Boucher CAB; Schmit JC; Wensing AMJ; ; Puchhammer-Stockl E; Sarcletti M; Schmied B; Geit M; Balluch G; Vandamme AM; Vercauteren J; Derdelinckx I; Sasse A; Bogaert M; Ceunen H; De Roo A; De Wit S; Echahidi F; Fransen K; Goffard JC; Goubau P; Goudeseune E; Yombi JC; Lacor P; Liesnard C; Moutschen M; Pierard D; Rens R; Schrooten Y; Vaira D; Vandekerckhove LPR; Van den Heuvel A; Van Der Gucht B; Van Ranst M; Van Wijngaerden E; Vandercam B; Vekemans M; Verhofstede C; Clumeck N; Van Laethem K; Beshkov D; Alexiev I; Lepej SZ; Begovac J; Kostrikis L; Demetriades I; Kousiappa I; Demetriou V; Hezka J; Linka M; Maly M; Machala L; Nielsen C; Jørgensen LB; Gerstoft J; Mathiesen L; Pedersen C; Nielsen H; Laursen A; Kvinesdal B; Liitsola K; Ristola M; Suni J; Sutinen J; Descamps D; Assoumou L; Castor G; Grude M; Flandre P; Storto A; Hamouda O; Kücherer C; Berg T; Braun P; Poggensee G; Däumer M; Eberle J; Heiken H; Kaiser R; Knechten H; Korn K; Müller H; Neifer S; Schmidt B; Walter H; Gunsenheimer-Bartmeyer B; Harrer T; Paraskevis D; Hatzakis A; Zavitsanou A; Vassilakis A; Lazanas M; Chini M; Lioni A; Sakka V; Kourkounti S; Paparizos V; Antoniadou A; Papadopoulos A; Poulakou G; Katsarolis I; Protopapas K; Chryssos G; Drimis S; Gargalianos P; Xylomenos G; Lourida G; Psichogiou M; Daikos GL; Sipsas NV; Kontos A; Gamaletsou MN; Koratzanis G; Sambatakou H; Mariolis H; Skoutelis A; Papastamopoulos V; Georgiou O; Panagopoulos P; Maltezos E; Coughlan S; De Gascun C; Byrne C; Duffy M; Bergin C; Reidy D; Farrell G; Lambert J; O'Connor E; Rochford A; Low J; Coakely P; O'Dea S; Hall W; Mor O; Levi I; Chemtob D; Grossman Z; Zazzi M; de Luca A; Balotta C; Riva C; Mussini C; Caramma I; Capetti A; Colombo MC; Rossi C; Prati F; Tramuto F; Vitale F; Ciccozzi M; Angarano G; Rezza G; Kolupajeva T; Vasins O; Griskevicius A; Lipnickiene V; Schmit JC; Struck D; Sauvageot N; Hemmer R; Arendt V; Michaux C; Staub T; Sequin-Devaux C; Wensing AMJ; Boucher CAB; van de Vijver DAMC; van Kessel A; van Bentum PHM; Brinkman K; Connell BJ; van der Ende ME; Hoepelman IM; van Kasteren M; Kuipers M; Langebeek N; Richter C; Santegoets RMWJ; Schrijnders-Gudde L; Schuurman R; van de Ven BJM; Åsjö B; Kran AB; Ormaasen V; Aavitsland P; Horban A; Stanczak JJ; Stanczak GP; Firlag-Burkacka E; Wiercinska-Drapalo A; Jablonowska E; Maolepsza E; Leszczyszyn-Pynka M; Szata W; Camacho R; Palma C; Borges F; Paixão T; Duque V; Araújo F; Otelea D; Paraschiv S; Tudor AM; Cernat R; Chiriac C; Dumitrescu F; Prisecariu LJ; Stanojevic M; Jevtovic D; Salemovic D; Stanekova D; Habekova M; Chabadová Z; Drobkova T; Bukovinova P; Shunnar A; Truska P; Poljak M; Lunar M; Babic D; Tomazic J; Vidmar L; Vovko T; Karner P; Garcia F; Paredes R; Monge S; Moreno S; Del Amo J; Asensi V; Sirvent JL; de Mendoza C; Delgado R; Gutiérrez F; Berenguer J; Garcia-Bujalance S; Stella N; de Los Santos I; Blanco JR; Dalmau D; Rivero M; Segura F; Elías MJP; Alvarez M; Chueca N; Rodríguez-Martín C; Vidal C; Palomares JC; Viciana I; Viciana P; Cordoba J; Aguilera A; Domingo P; Galindo MJ; Miralles C; Del Pozo MA; Ribera E; Iribarren JA; Ruiz L; de la Torre J; Vidal F; Clotet B; Albert J; Heidarian A; Aperia-Peipke K; Axelsson M; Mild M; Karlsson A; Sönnerborg A; Thalme A; Navér L; Bratt G; Karlsson A; Blaxhult A; Gisslén M; Svennerholm B; Bergbrant I; Björkman P; Säll C; Mellgren Å; Lindholm A; Kuylenstierna N; Montelius R; Azimi F; Johansson B; Carlsson M; Johansson E; Ljungberg B; Ekvall H; Strand A; Mäkitalo S; Öberg S; Holmblad P; Höfer M; Holmberg H; Josefson P; Ryding U
    Clin Infect Dis; 2016 Mar; 62(5):655-663. PubMed ID: 26620652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical, epidemiological and treatment failure data among HIV-1 non-B-infected patients in the Spanish AIDS Research Network Cohort.
    Torrecilla García E; Yebra Sanz G; Llácer-Delicado T; Rubio García R; González-García J; García García F; López-Aldeguer J; Asensi Álvarez V; Holguín Fernández Á;
    Enferm Infecc Microbiol Clin; 2016; 34(6):353-60. PubMed ID: 26364856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in Transmission of Drug Resistance and Prevalence of Non-B Subtypes in Patients with Acute or Recent HIV-1 Infection in Barcelona in the Last 16 Years (1997-2012).
    Ambrosioni J; Sued O; Nicolas D; Parera M; López-Diéguez M; Romero A; Agüero F; Marcos MÁ; Manzardo C; Zamora L; Gómez-Carrillo M; Gatell JM; Pumarola T; Miró JM
    PLoS One; 2015; 10(6):e0125837. PubMed ID: 26039689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transmitted Drug Resistance and HIV Diversity Among Adolescents Newly Diagnosed With HIV in Spain.
    Epalza C; Valadés-Alcaraz A; González-Alba JM; Beltrán-Pavez C; Gutiérrez-López M; Rubio-Garrido M; Fortuny C; Frick MA; Muñoz Medina L; Moreno S; Sanz J; Rojo P; Navarro ML; Holguín Á;
    Pediatr Infect Dis J; 2024 Jan; 43(1):40-48. PubMed ID: 37922511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology and Transmitted HIV-1 Drug Resistance among Treatment-Naïve Individuals in Israel, 2010-2018.
    Wagner T; Zuckerman NS; Halperin T; Chemtob D; Levy I; Elbirt D; Shachar E; Olshtain-Pops K; Elinav H; Chowers M; Itsomin V; Riesenberg K; Wax M; Shirazi R; Gozlan Y; Matus N; Girshengorn S; Marom R; Mendelson E; Turner D; Mor O
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV drug resistance tendencies in Latvia.
    Kolupajeva T; Aldins P; Guseva L; Dusacka D; Sondore V; Viksna L; Rozentale B
    Cent Eur J Public Health; 2008 Sep; 16(3):138-40. PubMed ID: 18935781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors.
    Bracciale L; Colafigli M; Zazzi M; Corsi P; Meraviglia P; Micheli V; Maserati R; Gianotti N; Penco G; Setti M; Di Giambenedetto S; Butini L; Vivarelli A; Trezzi M; De Luca A
    J Antimicrob Chemother; 2009 Sep; 64(3):607-15. PubMed ID: 19608581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of Transmitted HIV Drug Resistance Among Recently Infected Persons in San Diego, CA 1996-2013.
    Panichsillapakit T; Smith DM; Wertheim JO; Richman DD; Little SJ; Mehta SR
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):228-36. PubMed ID: 26413846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of transmitted drug resistance in Spain in the years 2007-2010 documents a decline in mutations to the non-nucleoside drug class.
    Monge S; Guillot V; Alvarez M; Peña A; Viciana P; García-Bujalance S; Pérez Elias MJ; Iribarren JA; Gutiérrez F; Itziar Casado M; Garcia F;
    Clin Microbiol Infect; 2012 Nov; 18(11):E485-90. PubMed ID: 23016666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.